Authors
Shevchenko Yu.L., Fedyk O.V., Miminoshvili L.G., Troshina A.A.
Pirogov National Medical and Surgical Center, Moscow
Abstract
Poststernotomy mediastinitis is a rare but severe complication of cardiac surgery with high mortality; the outcome largely depends on the timeliness of diagnosis and initiation of etiotropic therapy.
Description of the observation. A 60‑year‑old patient who had undergone coronary artery bypass grafting with the use of the left internal thoracic artery developed postoperative wound soaking on the third day after surgery, without overt signs of sternal instability or pronounced purulent discharge. However, a rapid increase in C‑reactive protein levels and leukocyte formula shift were observed, accompanied by significant changes in additional biomarkers (ESId, presepsin, and HLA‑DR expression on monocytes). These findings served as a basis for early chest CT imaging, which confirmed the diagnosis of sternomediastinitis, leading to the activation of surgical management (staged mediastinal debridement, vacuum‑assisted therapy, and subsequent sternal reconstruction using metallic implants).
Conclusion. This case demonstrates that an extended monitoring protocol of inflammatory biomarkers and immune status enables early suspicion of mediastinitis before the development of classical local manifestations and allows timely adjustment of treatment strategy.
Keywords: poststernotomy mediastinitis; coronary artery bypass grafting; inflammatory biomarkers; presepsin; HLA‑DR (MHC‑II); ESId; vacuum therapy.
References
1. De Feo M, Della Corte A, Vicchio M, et al. Is post-sternotomy mediastinitis still devastating after the advent of negative-pressure wound therapy? Tex Heart Inst J. 2011; 38: 375-380.
2. Schimmer C, Sommer SP, Bensch M, et al. Management of poststernotomy mediastinitis: experience and results of different therapy modalities. Thorac Cardiovasc Surg. 2008; 56: 200-204.
3. SHevchenko YUL, Susov RP. Posleoperacionnye infekcionno-vospalitel’nye oslozhneniya v kardiotorakal’noj hirurgii. Vestnik Nacional’nogo mediko-hirurgicheskogo centra im. N.I. Pirogova. 2022; 17(1): 84-89. (In Russ.)
4. SHevchenko YUL, Matveev SA, Makarov AA, Hlebov VF. Lechenie ostrogo perednego mediastinita posle operacij na otkrytom serdce. Aktual’nye problemy gnojno-septicheskih infekcij. SPb., 1996. Р.106-107. (In Russ.)
5. Gorbunov VA, Dzhordzhikiya RK, Mukharyamov MN, Vagizov II. Management of post-sternotomy mediastinitis in cardiac patients. Pirogov Russian Journal of Surgery. 2016; 11: 41-45. (In Russ.) doi: 10.17116/hirurgia201611241-45.
6. Woo A, Oh DK, Park C-J, et al. Monocyte distribution width compared with C-reactive protein and procalcitonin for early sepsis detection in the emergency department. PLoS ONE 2021; 16(4): e0250101. doi: 10.1371/journal. pone.0250101.
7. Schuetz P, Beishuizen A, Broyles M, et al. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clin Chem Lab Med. 2019; 57(9): 1308-1318. doi: 10.1515/ cclm-2018-1181.
8. Amanai E, Nakai K, Saito J, et al. Usefulness of presepsin for the early detection of infectious complications after elective colorectal surgery, compared with C-reactive protein and procalcitonin. Scientific Reports 2022; 12(1): 3960. doi: 10.1038/s41598-022-06613-w.
9. Crouser ED, Parrillo JE, Seymour CW, et al. Monocyte distribution width enhances early sepsis detection in the emergency department beyond SIRS and qSOFA. Crouser et al. Journal of Intensive Care 2020; 8(33). doi: 10.1186/ s40560-020-00446-3.
10. Quirant-Sánchez B, Plans-Galván O, Lucas E, et al. HLA-DR Expression on Monocytes and Sepsis Index Are Useful in Predicting Sepsis. Biomedicines 2023; 11(7): 1836. doi: 10.3390/biomedicines11071836.
11. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021; 47: 1181-1247. doi: 10.1007/s00134-021-06506-y.
